Reimbursed Care Access in Albania

Currently classified as a strictly controlled substance under Albania’s narcotics scheduling (hallucinogens listed in national drug control lists), with no authorized medical use outside of approved clinical research. # #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Possession of small personal amounts has been treated leniently in some case law, but manufacture, distribution and sale carry severe criminal penalties. # #

Esketamine (Spravato) is not listed in publicly available Albanian marketing/registration summaries and there is no evidence of a national reimbursement pathway or approved psychiatric indication in Albania. Albania requires registration with the National Agency of Drug Control and Medical Equipment for marketed medicines and prioritizes drugs with EMA/FDA authorizations for registration pathways, but no Albanian public source shows a registered esketamine product. As such, esketamine is not part of standard, reimbursed care and would only be accessible if imported under special authorization or used in private arrangements if a clinician and hospital obtained the product and necessary approvals. # #

Ketamine is an approved and routinely procured anesthetic/analgesic agent in Albanian hospitals, purchased via Ministry of Health tenders and used in surgical, emergency and other medical settings; public procurement records show active tendering and contracting for ketamine ampoules for multiple hospitals and the Ministry of Health. Use of ketamine for psychiatric indications (e.g., subanesthetic infusions for treatment‑resistant depression) would be considered off‑label and is not established as a reimbursed, standardized mental‑health therapy in Albania—access would therefore typically be private (hospital/clinic‑level) and arranged by treating physicians on an off‑label basis. There is no published national clinical program or reimbursement policy covering psychedelic‑assisted psychiatric ketamine infusions. # # #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Domestic possession, production or distribution outside an authorized study would be illegal. #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. There is no recognized medical or reimbursement pathway for ibogaine in Albania. #

Because ayahuasca contains DMT (a controlled hallucinogen), preparation, possession or distribution of ayahuasca is covered by Albania’s controlled substances framework and is not authorized medically outside approved research; no reimbursement or medical program exists. #

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Traditional sacramental exceptions are not codified in Albanian law; there is no medical reimbursement pathway. #

Currently classified as a strictly controlled substance under national drug scheduling laws (2C family identified among hallucinogens), with no authorized medical use outside of approved clinical research. #